Pharma Journalist -

IntoCell Inc., a biotechnology company specializing in next-generation payload and linker technologies for antibody–drug conjugates (ADCs), has entered into a strategic collaboration…
Read More...

Helex, a biotechnology company developing targeted therapies for genetic kidney diseases, has announced the completion of an oversubscribed $3.5 million Seed round led by pi Ventures,…
Read More...

Dewpoint Therapeutics, a biotechnology company pioneering condensate biology, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to…
Read More...

Eli Lilly and Company announced plans to invest over $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico, strengthening its U.S.…
Read More...

Novo Nordisk has confirmed submitting an unsolicited proposal to acquire U.S.-based Metsera, Inc., a biotechnology company developing early- and mid-stage incretin and non-incretin…
Read More...

Swiss biopharmaceutical company Debiopharm has entered into a strategic research collaboration with South Korea–based biotech firm NetTargets to accelerate the discovery of novel,…
Read More...

Seres Therapeutics, Inc. announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) has awarded the company up to $3.6 million in additional…
Read More...

The U.S. Food and Drug Administration (FDA) has unveiled a new draft guidance aimed at making the development of biosimilar medicines—lower-cost alternatives to expensive biologic…
Read More...

London, UK – 30 October 2025 – SAE Media Group has officially unveiled the agenda for the 7th Annual AI in Drug Discovery conference, taking place 9–10 March 2026 at the Hilton London…
Read More...

Alexion, AstraZeneca Rare Disease, announced that the European Commission has approved Koselugo (selumetinib) for the treatment of symptomatic, inoperable plexiform neurofibromas (PN)…
Read More...